$120Million– No. of Holdings #77
| Ticker | $ Bought |
|---|---|
| iqvia holdings inc | 1,416,680 |
| bristol myers squibb | 1,282,750 |
| medtronic plc | 961,815 |
| ardelyx inc | 781,060 |
| agomab therapeutics | 477,295 |
| abivax sa | 297,861 |
| medpace holdings | 228,090 |
| guardant health inc | 205,523 |
| Ticker | % Inc. |
|---|---|
| ars pharmaceuticals | 165 |
| insmed inc | 75.89 |
| gilead sciences inc | 53.7 |
| kura oncology inc | 32.1 |
| biontech se | 28.73 |
| boston scientific | 25.9 |
| cytokinetics inc | 23.88 |
| argenx se | 23.15 |
| Ticker | % Reduced |
|---|---|
| tectonic therapeutic | -54.9 |
| syndax pharmaceutics | -48.24 |
| structure therapeutics | -40.93 |
| rapport therapeutics | -34.69 |
| cogent biosciences | -32.26 |
| vera therapeutics | -30.62 |
| beone medicines ltd | -29.83 |
| omada health inc | -29.81 |
| Ticker | $ Sold |
|---|---|
| ventyx biosciences | -875,413 |
| carlsmed inc | -589,095 |
| amicus therapeutics | -616,592 |
| lenz therapeutics inc | -680,000 |
| astrazeneca | -1,400,280 |
| tempus ai inc | -265,725 |
| madrigal pharma | -204,984 |
SECTORAL ASSET MANAGEMENT INC has about 65% of it's holdings in Healthcare sector.
| Sector | % |
|---|---|
| Healthcare | 65 |
| Others | 34.5 |
SECTORAL ASSET MANAGEMENT INC has about 55% of it's portfolio invested in the large-cap and mega-cap stocks.
| Category | % |
|---|---|
| LARGE-CAP | 38.3 |
| UNALLOCATED | 34.5 |
| MEGA-CAP | 16.7 |
| MID-CAP | 5.6 |
| SMALL-CAP | 4.8 |
About 58.3% of the stocks held by SECTORAL ASSET MANAGEMENT INC either belong to S&P 500 or RUSSELL 2000 index.
| Index | % |
|---|---|
| S&P 500 | 45 |
| Others | 41.7 |
| RUSSELL 2000 | 13.3 |
This heatmap illustrates the top 50 positions within the fund's portfolio.
SECTORAL ASSET MANAGEMENT INC has 77 stocks in it's portfolio. About 48.1% of the portfolio is in top 10 stocks. LLY proved to be the most loss making stock for the portfolio. was the most profitable stock for SECTORAL ASSET MANAGEMENT INC last quarter.
Last Reported on: 15 May, 2026| Ticker | Namesorted ascending | % Portfolio | Shares Held | $ Value | Type | % Change | Options | |
|---|---|---|---|---|---|---|---|---|
| ABBV | abbvie inc | 2.20 | 12,200 | 2,653,380 | reduced | -27.38 | ||
| ABT | abbott labs | 2.17 | 25,578 | 2,626,090 | added | 8.85 | ||
| ALHC | alignment health | 0.39 | 26,911 | 474,172 | reduced | -14.57 | ||
| ALNY | alnylam pharmacuetcl | 0.72 | 2,310 | 864,232 | reduced | -22.74 | ||
| AMGN | amgen inc | 2.91 | 9,210 | 3,514,980 | reduced | -29.53 | ||
| ARDX | ardelyx inc | 0.65 | 122,394 | 781,060 | new | |||
| ARGX | argenx se | 2.27 | 3,564 | 2,736,980 | added | 23.15 | ||
| ASND | ascendis pharma a s | 0.60 | 2,800 | 728,276 | reduced | -13.95 | ||
| AXSM | axsome therapeutic | 0.24 | 1,500 | 289,869 | reduced | -13.79 | ||
| AZN | astrazeneca | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| BBIO | bridgebio pharma | 0.57 | 8,100 | 687,276 | reduced | -27.48 | ||
| BGNE | beone medicines ltd | 0.52 | 1,870 | 631,061 | reduced | -29.83 | ||
| BIIB | biogen inc | 0.32 | 1,850 | 385,910 | reduced | -14.15 | ||
| BMRN | biomarin pharmac | 0.50 | 9,450 | 607,268 | reduced | -13.14 | ||
| BMY | bristol myers squibb | 1.06 | 21,150 | 1,282,750 | new | |||
| BNTX | biontech se | 1.69 | 22,164 | 2,045,310 | added | 28.73 | ||
| BSX | boston scientific | 1.81 | 34,780 | 2,182,440 | added | 25.9 | ||
| COGT | cogent biosciences | 0.75 | 22,140 | 902,398 | reduced | -32.26 | ||
| CYTK | cytokinetics inc | 0.45 | 7,300 | 544,614 | added | 23.88 | ||
| DHR | danaher corp | 1.51 | 9,597 | 1,819,590 | reduced | -9.25 | ||